Just a reminder that presidents on both sides have been effective at expanding access to care and health innovation. Seeing some of the press around health legislation this week, let’s hope this administration can craft some wins, too. The ACA wasn’t perfect; time to evolve:
As we look to “Repeal and Replace”, it’s important to acknowledge how ACA has improved access
Your Portfolio Archive currently has no entries. You can start creating them on your dashboard.
Merilytic Health brings strategy and operational consulting services, unique analytic approaches and technologies to health services companies. Merilytic Health’s first venture, PharmacyAnalytics, can be found at www.pharmacyanalytics.com.
Merilytic Health is led by Erin Rebholz, who has over 19 years of experience in corporate development, strategy, and analytics roles. Through her work, Erin has developed a broad understanding of the US and Global healthcare markets, with experiences across the value chain, including: integrated health systems, retail pharmacy, long term care and home health care sectors, payors, pharmaceutical companies and government agencies.
Erin worked for McKesson Corporation, a global supplier of pharmaceutical products, technology, and services, most recently as Vice President of Analytic Services and also as Director of Corporate Strategy and Business Development. Prior to McKesson, Erin worked at Booz Allen Hamilton as part of their strategy consulting practice (now Strategy&, part of Price Waterhouse Coopers), where she served healthcare, energy, financial services and non-profit clients. Erin holds a Master’s degree in business administration from The Wharton School at the University of Pennsylvania and a Bachelor’s of Science degree in chemical engineering from Brown University.
LinkedIn profile available here: http://www.linkedin.com/in/ekrebholz